Research Article

Laboratory Investigation (2005) 85, 1024–1039. doi:10.1038/labinvest.3700293; published online 23 May 2005

Patient-based cross-platform comparison of oligonucleotide microarray expression profiles

Joerg Schlingemann1,*, Negusse Habtemichael2,*, Carina Ittrich3, Grischa Toedt1, Heidi Kramer1, Markus Hambek4, Rainald Knecht4, Peter Lichter1, Roland Stauber2 and Meinhard Hahn1

  1. 1Division of Molecular Genetics, Deutsches Krebsforschungszentrum, Heidelberg, Germany
  2. 2Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany
  3. 3Central Unit Biostatistics, Deutsches Krebsforschungszentrum, Heidelberg, Germany
  4. 4Department of Otorhinolaryngology, Universitätsklinik, Johann-Wolfgang-Goethe-Universität Frankfurt, Frankfurt, Germany

Correspondence: Dr M Hahn, PhD, Division of Molecular Genetics, Deutsches Krebsforschungszentrum, INF 280, D-69120 Heidelberg, Germany and Dr R Stauber, PhD, Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Str. 42-44, D-60596 Frankfurt am Main, Germany. E-mails: m.hahn@dkfz.de, stauber@em.uni-frankfurt.de

*These two authors contributed equally to this study.

Received 21 February 2005; Revised 8 April 2005; Accepted 9 April 2005; Published online 23 May 2005.

Top

Abstract

The comparison of gene expression measurements obtained with different technical approaches is of substantial interest in order to clarify whether interplatform differences may conceal biologically significant information. To address this concern, we analyzed gene expression in a set of head and neck squamous cell carcinoma patients, using both spotted oligonucleotide microarrays made from a large collection of 70-mer probes and commercial arrays produced by in situ synthesis of sets of multiple 25-mer oligonucleotides per gene. Expression measurements were compared for 4425 genes represented on both platforms, which revealed strong correlations between the corresponding data sets. Of note, a global tendency towards smaller absolute ratios was observed when using the 70-mer probes. Real-time quantitative reverse transcription PCR measurements were conducted to verify expression ratios for a subset of genes and achieved good agreement regarding both array platforms. In conclusion, similar profiles of relative gene expression were obtained using arrays of either single 70-mer or multiple short 25-mer oligonucleotide probes per gene. Although qualitative assessments of the expression of individual genes have to be made with caution, our results indicate that the comparison of gene expression profiles generated on these platforms will help to discover disease-related gene signatures in general.

Keywords:

comparative study, expression profiling, head and neck cancer, oligonucleotide microarray, oligonucleotide probes, reproducibility of results, statistics and numerical data

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Of fish and chips

Nature Methods News and Views (01 May 2005)

On the bright side of microarrays

Nature Cell Biology News and Views (01 Jun 2005)

Extra navigation

.

naturejobs

ADVERTISEMENT